Study Evaluating UCART20x22 in B-Cell Non-Hodgkin Lymphoma - Join Clinical Trial NCTNCT05607420
How to Join This Clinical Trial - NCTNCT05607420
Learn how to participate in this PHASE1, PHASE2 trial studying an investigational therapy for B-cell Non-Hodgkin Lymphoma (B-NHL). This study is currently enrolling participants.
Am I Eligible for This Clinical Trial?
This clinical research study is looking for participants with B-cell Non-Hodgkin Lymphoma (B-NHL). Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.
- Condition Being Studied
- B-cell Non-Hodgkin Lymphoma (B-NHL)
- Treatment Being Tested
- Investigational treatment
- Study Phase
- PHASE1, PHASE2 - Safety and effectiveness study
- Enrollment Status
- Currently enrolling participants
- Study Identifier
- NCTNCT05607420 - ClinicalTrials.gov Identifier
- Sponsored By
- Study sponsor
What to Expect as a Participant
Participating in this clinical trial involves:
- Initial screening to determine eligibility
- Regular study visits and health assessments
- Receiving the study treatment or placebo
- Medical monitoring and follow-up care
- Contributing to medical research that may help others
- Potential access to new treatments before they're widely available
Clinical Trial Benefits and Compensation
Participants in this clinical research study may receive:
- Close medical monitoring by healthcare professionals
- Access to potential new treatments
- Compensation for time and travel (varies by study)
- No-cost study-related medical care
- The opportunity to help advance medical knowledge
Where Is This Clinical Trial Located?
This study is enrolling participants at 10 locations. Find a study site near you:
Clinical Research Site
Chicago, Illinois 60637 - United States
Status: RECRUITING
Clinical Research Site
Boston, Massachusetts 02114 - United States
Status: RECRUITING
Clinical Research Site
New Brunswick, New Jersey 08901 - United States
Status: RECRUITING
Clinical Research Site
Austin, Texas 78704 - United States
Status: RECRUITING
Clinical Research Site
Pierre-Bénite, Auvergne Rhone Alpe 69310 - France
Status: RECRUITING
Clinical Research Site
Montpellier, Occitanie 34295 - France
Status: RECRUITING
Clinical Research Site
Nantes, 44093 - France
Status: RECRUITING
Clinical Research Site
Paris, Île-de-France Region 75010 - France
Status: RECRUITING
Clinical Research Site
Pamplona, Navarre 31008 - Spain
Status: RECRUITING
Clinical Research Site
Seville, 41013 - Spain
Status: RECRUITING
How to Enroll in This Study
To learn more about participating in this PHASE1, PHASE2 clinical trial for B-cell Non-Hodgkin Lymphoma (B-NHL):
- Review the eligibility criteria with your healthcare provider
- Contact the study team for a pre-screening interview
- Schedule an in-person screening visit if eligible
- Review and sign the informed consent form
- Begin participation in the clinical trial
Why Choose Quri.ai Study Finder
Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:
- Discover clinical trials before competitors
- Access exclusive contact information
- Track sponsor pipelines and opportunities
- Connect with decision makers directly
- Win more business partnerships